S100A9 and systemic lupus erythematosus: Recent research suggests that S100A9 is a crucial pro-inflammatory pathogenic molecule that is extensively expressed in several autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, and Sjögren’s syndrome [18–22].